Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes

Metabolism: Clinical and Experimental

Volumn 64, Issue 4, 2015, Pages 489-497

  Higuchi, Chigusa ^a   Nakatsuka, Atsuko ^a   Eguchi, Jun ^a   Teshigawara, Sanae ^a   Kanzaki, Motoko ^a   Katayama, Akihiro ^a   Yamaguchi, Satoshi ^a   Takahashi, Naoto ^a   Murakami, Kazutoshi ^a   Ogawa, Daisuke ^a   Sasaki, Sakiko ^b   Makino, Hirofumi ^a   Wada, Jun ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Okayama Southern Institute of Health   (Japan)

Author keywords

Adipose tissues; Diabetes; Liver; miRNA; Serum

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MICRORNA; MICRORNA 101; MICRORNA 375; MICRORNA 802; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; MIRN101 MICRORNA, HUMAN; MIRN375 MICRORNA, HUMAN; MIRN802 MICRORNA, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DIABETIC PATIENT; DIET INDUCED OBESITY; EPIDIDYMIS; FEMALE; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; LIVER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION SYSTEM; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; WHITE ADIPOSE TISSUE; AGED; ANIMAL; BLOOD; C57BL MOUSE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; METABOLISM;

ADULT; AGED; ANIMALS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MIDDLE AGED;

EID: 84923539215     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.12.003     Document Type: Article

References (29)

1. V.N. Kim, J. Han, and M.C. Siomi Biogenesis of small RNAs in animals Nat Rev Mol Cell Biol 10 2009 126 139
2. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, and E.L. Pogosova-Agadjanyan Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci U S A 105 2008 10513 10518
3. R.A. Boon, and K.C. Vickers Intercellular transport of microRNAs Arterioscler Thromb Vasc Biol 33 2013 186 192
4. K.C. Vickers, and A.T. Remaley Lipid-based carriers of microRNAs and intercellular communication Curr Opin Lipidol 23 2012 91 97
5. C. Guay, and R. Regazzi Circulating microRNAs as novel biomarkers for diabetes mellitus Nat Rev Endocrinol 9 2013 513 521
6. L.B. Nielsen, C. Wang, K. Sorensen, C.H. Bang-Berthelsen, L. Hansen, and M.L. Andersen Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression Exp Diabetes Res 2012 2012 896362
7. Y. Rong, W. Bao, Z. Shan, J. Liu, X. Yu, and S. Xia Increased microRNA-146a levels in plasma of patients with newly diagnosed type 2 diabetes mellitus PLoS One 8 2013 e73272
8. F.J. Ortega, J.M. Mercader, J.M. Moreno-Navarrete, O. Rovira, E. Guerra, and E. Esteve Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization Diabetes Care 37 2014 1375 1383
9. X. Wang, J. Sundquist, B. Zoller, A.A. Memon, K. Palmer, and K. Sundquist Determination of 14 circulating microRNAs in Swedes and Iraqis with and without diabetes mellitus type 2 PLoS One 9 2014 e86792
10. Z. Yang, H. Chen, H. Si, X. Li, X. Ding, and Q. Sheng Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes Acta Diabetol 51 2014 823 831
11. R. Li, A.C. Chung, X. Yu, and H.Y. Lan MicroRNAs in diabetic kidney disease Int J Endocrinol 2014 2014 593956
12. G. Mao, and L. Liu microRNA-18a is a genetic marker for the early diagnosis of cerebral injury induced by type 2 diabetes Exp Ther Med 8 2014 1901 1905
13. S. Qing, S. Yuan, C. Yun, H. Hui, P. Mao, and F. Wen Serum MiRNA biomarkers serve as a fingerprint for proliferative diabetic retinopathy Cell Physiol Biochem 34 2014 1733 1740
14. F.J. Ortega, J.M. Mercader, V. Catalan, J.M. Moreno-Navarrete, N. Pueyo, and M. Sabater Targeting the circulating microRNA signature of obesity Clin Chem 59 2013 781 792
15. N. Pescador, M. Perez-Barba, J.M. Ibarra, A. Corbaton, M.T. Martinez-Larrad, and M. Serrano-Rios Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers PLoS One 8 2013 e77251
16. D.S. Karolina, S. Tavintharan, A. Armugam, S. Sepramaniam, S.L. Pek, and M.T. Wong Circulating miRNA profiles in patients with metabolic syndrome J Clin Endocrinol Metab 97 2012 E2271 E2276
17. M.N. Poy, L. Eliasson, J. Krutzfeldt, S. Kuwajima, X. Ma, and P.E. Macdonald A pancreatic islet-specific microRNA regulates insulin secretion Nature 432 2004 226 230
18. M.V. Joglekar, V.M. Joglekar, and A.A. Hardikar Expression of islet-specific microRNAs during human pancreatic development Gene Expr Patterns 9 2009 109 113
19. M.N. Poy, J. Hausser, M. Trajkovski, M. Braun, S. Collins, and P. Rorsman miR-375 maintains normal pancreatic alpha- and beta-cell mass Proc Natl Acad Sci U S A 106 2009 5813 5818
20. R. Lahmy, M. Soleimani, M.H. Sanati, M. Behmanesh, F. Kouhkan, and N. Mobarra miRNA-375 promotes beta pancreatic differentiation in human induced pluripotent stem (hiPS) cells Mol Biol Rep 2014
21. K. Sun, X. Chang, L. Yin, J. Li, T. Zhou, and C. Zhang Expression and DNA methylation status of microRNA-375 in patients with type 2 diabetes mellitus Mol Med Rep 9 2014 967 972
22. O. Nakahara, H. Takamori, M. Iwatsuki, Y. Baba, Y. Sakamoto, and H. Tanaka Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2 Ann Surg Oncol 19 Suppl. 3 2012 S565 S571
23. C. Chakraborty, C. George Priya Doss, and S. Bandyopadhyay miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the 'minute and miracle' molecule moving as a monitor in the 'genomic galaxy' Curr Drug Targets 14 2013 1110 1117
24. J.W. Kornfeld, C. Baitzel, A.C. Konner, H.T. Nicholls, M.C. Vogt, and K. Herrmanns Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b Nature 494 2013 111 115
25. N. Nakanishi, Y. Nakagawa, N. Tokushige, N. Aoki, T. Matsuzaka, and K. Ishii The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice Biochem Biophys Res Commun 385 2009 492 496
26. L. Zhu, L. Chen, C.M. Shi, G.F. Xu, L.L. Xu, and L.L. Zhu MiR-335, an adipogenesis-related microRNA, is involved in adipose tissue inflammation Cell Biochem Biophys 68 2014 283 290
27. J.L. Esguerra, C. Bolmeson, C.M. Cilio, and L. Eliasson Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat PLoS One 6 2011 e18613
28. A. Reiner, D. Yekutieli, and Y. Benjamini Identifying differentially expressed genes using false discovery rate controlling procedures Bioinformatics 19 2003 368 375
29. J.D. Storey, and R. Tibshirani Statistical significance for genomewide studies Proc Natl Acad Sci U S A 100 2003 9440 9445